Home > > > > > Report Detail

Global Capecitabine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publisher Name :
Date: 02-Jan-2023
No. of pages: 92

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.

According to our (Global Info Research) latest study, the global Capecitabine market size was valued at USD 1055.9 million in 2022 and is forecast to a readjusted size of USD 1027.9 million by 2029 with a CAGR of -0.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Roche, Teva and Mylan are the top 3 of Capecitabine, with about 87% market shares.

This report is a detailed and comprehensive analysis for global Capecitabine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Capecitabine market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2018-2029

Global Capecitabine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2018-2029

Global Capecitabine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2018-2029

Global Capecitabine market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/g), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Capecitabine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Capecitabine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Teva, Mylan, Hikma and Hengrui Medicine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Capecitabine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

- 500 mg

- 150 mg

Market segment by Application

- Breast Cancer

- Colorectal Cancer

- Stomach Cancer

Major players covered

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Market segment by region, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

- South America (Brazil, Argentina, Colombia, and Rest of South America)

- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Capecitabine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Capecitabine, with price, sales, revenue and global market share of Capecitabine from 2018 to 2023.

Chapter 3, the Capecitabine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Capecitabine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Capecitabine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Capecitabine.

Chapter 14 and 15, to describe Capecitabine sales channel, distributors, customers, research findings and conclusion.

Global Capecitabine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Capecitabine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 500 mg
1.3.3 150 mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Capecitabine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Colorectal Cancer
1.4.4 Stomach Cancer
1.5 Global Capecitabine Market Size & Forecast
1.5.1 Global Capecitabine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Capecitabine Sales Quantity (2018-2029)
1.5.3 Global Capecitabine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Capecitabine Product and Services
2.1.4 Roche Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Capecitabine Product and Services
2.2.4 Teva Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Capecitabine Product and Services
2.3.4 Mylan Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan Recent Developments/Updates
2.4 Hikma
2.4.1 Hikma Details
2.4.2 Hikma Major Business
2.4.3 Hikma Capecitabine Product and Services
2.4.4 Hikma Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hikma Recent Developments/Updates
2.5 Hengrui Medicine
2.5.1 Hengrui Medicine Details
2.5.2 Hengrui Medicine Major Business
2.5.3 Hengrui Medicine Capecitabine Product and Services
2.5.4 Hengrui Medicine Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hengrui Medicine Recent Developments/Updates
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Capecitabine Product and Services
2.6.4 Cipla Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cipla Recent Developments/Updates
2.7 Reliance Group
2.7.1 Reliance Group Details
2.7.2 Reliance Group Major Business
2.7.3 Reliance Group Capecitabine Product and Services
2.7.4 Reliance Group Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Reliance Group Recent Developments/Updates
2.8 Hetero
2.8.1 Hetero Details
2.8.2 Hetero Major Business
2.8.3 Hetero Capecitabine Product and Services
2.8.4 Hetero Capecitabine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hetero Recent Developments/Updates
3 Competitive Environment: Capecitabine by Manufacturer
3.1 Global Capecitabine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Capecitabine Revenue by Manufacturer (2018-2023)
3.3 Global Capecitabine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Capecitabine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Capecitabine Manufacturer Market Share in 2022
3.4.2 Top 6 Capecitabine Manufacturer Market Share in 2022
3.5 Capecitabine Market: Overall Company Footprint Analysis
3.5.1 Capecitabine Market: Region Footprint
3.5.2 Capecitabine Market: Company Product Type Footprint
3.5.3 Capecitabine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Capecitabine Market Size by Region
4.1.1 Global Capecitabine Sales Quantity by Region (2018-2029)
4.1.2 Global Capecitabine Consumption Value by Region (2018-2029)
4.1.3 Global Capecitabine Average Price by Region (2018-2029)
4.2 North America Capecitabine Consumption Value (2018-2029)
4.3 Europe Capecitabine Consumption Value (2018-2029)
4.4 Asia-Pacific Capecitabine Consumption Value (2018-2029)
4.5 South America Capecitabine Consumption Value (2018-2029)
4.6 Middle East and Africa Capecitabine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Capecitabine Sales Quantity by Type (2018-2029)
5.2 Global Capecitabine Consumption Value by Type (2018-2029)
5.3 Global Capecitabine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Capecitabine Sales Quantity by Application (2018-2029)
6.2 Global Capecitabine Consumption Value by Application (2018-2029)
6.3 Global Capecitabine Average Price by Application (2018-2029)
7 North America
7.1 North America Capecitabine Sales Quantity by Type (2018-2029)
7.2 North America Capecitabine Sales Quantity by Application (2018-2029)
7.3 North America Capecitabine Market Size by Country
7.3.1 North America Capecitabine Sales Quantity by Country (2018-2029)
7.3.2 North America Capecitabine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Capecitabine Sales Quantity by Type (2018-2029)
8.2 Europe Capecitabine Sales Quantity by Application (2018-2029)
8.3 Europe Capecitabine Market Size by Country
8.3.1 Europe Capecitabine Sales Quantity by Country (2018-2029)
8.3.2 Europe Capecitabine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Capecitabine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Capecitabine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Capecitabine Market Size by Region
9.3.1 Asia-Pacific Capecitabine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Capecitabine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Capecitabine Sales Quantity by Type (2018-2029)
10.2 South America Capecitabine Sales Quantity by Application (2018-2029)
10.3 South America Capecitabine Market Size by Country
10.3.1 South America Capecitabine Sales Quantity by Country (2018-2029)
10.3.2 South America Capecitabine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Capecitabine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Capecitabine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Capecitabine Market Size by Country
11.3.1 Middle East & Africa Capecitabine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Capecitabine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Capecitabine Market Drivers
12.2 Capecitabine Market Restraints
12.3 Capecitabine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Capecitabine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Capecitabine
13.3 Capecitabine Production Process
13.4 Capecitabine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Capecitabine Typical Distributors
14.3 Capecitabine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Capecitabine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Capecitabine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Capecitabine Product and Services
Table 6. Roche Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Capecitabine Product and Services
Table 11. Teva Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Capecitabine Product and Services
Table 16. Mylan Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mylan Recent Developments/Updates
Table 18. Hikma Basic Information, Manufacturing Base and Competitors
Table 19. Hikma Major Business
Table 20. Hikma Capecitabine Product and Services
Table 21. Hikma Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hikma Recent Developments/Updates
Table 23. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 24. Hengrui Medicine Major Business
Table 25. Hengrui Medicine Capecitabine Product and Services
Table 26. Hengrui Medicine Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hengrui Medicine Recent Developments/Updates
Table 28. Cipla Basic Information, Manufacturing Base and Competitors
Table 29. Cipla Major Business
Table 30. Cipla Capecitabine Product and Services
Table 31. Cipla Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cipla Recent Developments/Updates
Table 33. Reliance Group Basic Information, Manufacturing Base and Competitors
Table 34. Reliance Group Major Business
Table 35. Reliance Group Capecitabine Product and Services
Table 36. Reliance Group Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Reliance Group Recent Developments/Updates
Table 38. Hetero Basic Information, Manufacturing Base and Competitors
Table 39. Hetero Major Business
Table 40. Hetero Capecitabine Product and Services
Table 41. Hetero Capecitabine Sales Quantity (Kg), Average Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hetero Recent Developments/Updates
Table 43. Global Capecitabine Sales Quantity by Manufacturer (2018-2023) & (Kg)
Table 44. Global Capecitabine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 45. Global Capecitabine Average Price by Manufacturer (2018-2023) & (USD/g)
Table 46. Market Position of Manufacturers in Capecitabine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 47. Head Office and Capecitabine Production Site of Key Manufacturer
Table 48. Capecitabine Market: Company Product Type Footprint
Table 49. Capecitabine Market: Company Product Application Footprint
Table 50. Capecitabine New Market Entrants and Barriers to Market Entry
Table 51. Capecitabine Mergers, Acquisition, Agreements, and Collaborations
Table 52. Global Capecitabine Sales Quantity by Region (2018-2023) & (Kg)
Table 53. Global Capecitabine Sales Quantity by Region (2024-2029) & (Kg)
Table 54. Global Capecitabine Consumption Value by Region (2018-2023) & (USD Million)
Table 55. Global Capecitabine Consumption Value by Region (2024-2029) & (USD Million)
Table 56. Global Capecitabine Average Price by Region (2018-2023) & (USD/g)
Table 57. Global Capecitabine Average Price by Region (2024-2029) & (USD/g)
Table 58. Global Capecitabine Sales Quantity by Type (2018-2023) & (Kg)
Table 59. Global Capecitabine Sales Quantity by Type (2024-2029) & (Kg)
Table 60. Global Capecitabine Consumption Value by Type (2018-2023) & (USD Million)
Table 61. Global Capecitabine Consumption Value by Type (2024-2029) & (USD Million)
Table 62. Global Capecitabine Average Price by Type (2018-2023) & (USD/g)
Table 63. Global Capecitabine Average Price by Type (2024-2029) & (USD/g)
Table 64. Global Capecitabine Sales Quantity by Application (2018-2023) & (Kg)
Table 65. Global Capecitabine Sales Quantity by Application (2024-2029) & (Kg)
Table 66. Global Capecitabine Consumption Value by Application (2018-2023) & (USD Million)
Table 67. Global Capecitabine Consumption Value by Application (2024-2029) & (USD Million)
Table 68. Global Capecitabine Average Price by Application (2018-2023) & (USD/g)
Table 69. Global Capecitabine Average Price by Application (2024-2029) & (USD/g)
Table 70. North America Capecitabine Sales Quantity by Type (2018-2023) & (Kg)
Table 71. North America Capecitabine Sales Quantity by Type (2024-2029) & (Kg)
Table 72. North America Capecitabine Sales Quantity by Application (2018-2023) & (Kg)
Table 73. North America Capecitabine Sales Quantity by Application (2024-2029) & (Kg)
Table 74. North America Capecitabine Sales Quantity by Country (2018-2023) & (Kg)
Table 75. North America Capecitabine Sales Quantity by Country (2024-2029) & (Kg)
Table 76. North America Capecitabine Consumption Value by Country (2018-2023) & (USD Million)
Table 77. North America Capecitabine Consumption Value by Country (2024-2029) & (USD Million)
Table 78. Europe Capecitabine Sales Quantity by Type (2018-2023) & (Kg)
Table 79. Europe Capecitabine Sales Quantity by Type (2024-2029) & (Kg)
Table 80. Europe Capecitabine Sales Quantity by Application (2018-2023) & (Kg)
Table 81. Europe Capecitabine Sales Quantity by Application (2024-2029) & (Kg)
Table 82. Europe Capecitabine Sales Quantity by Country (2018-2023) & (Kg)
Table 83. Europe Capecitabine Sales Quantity by Country (2024-2029) & (Kg)
Table 84. Europe Capecitabine Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Capecitabine Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Capecitabine Sales Quantity by Type (2018-2023) & (Kg)
Table 87. Asia-Pacific Capecitabine Sales Quantity by Type (2024-2029) & (Kg)
Table 88. Asia-Pacific Capecitabine Sales Quantity by Application (2018-2023) & (Kg)
Table 89. Asia-Pacific Capecitabine Sales Quantity by Application (2024-2029) & (Kg)
Table 90. Asia-Pacific Capecitabine Sales Quantity by Region (2018-2023) & (Kg)
Table 91. Asia-Pacific Capecitabine Sales Quantity by Region (2024-2029) & (Kg)
Table 92. Asia-Pacific Capecitabine Consumption Value by Region (2018-2023) & (USD Million)
Table 93. Asia-Pacific Capecitabine Consumption Value by Region (2024-2029) & (USD Million)
Table 94. South America Capecitabine Sales Quantity by Type (2018-2023) & (Kg)
Table 95. South America Capecitabine Sales Quantity by Type (2024-2029) & (Kg)
Table 96. South America Capecitabine Sales Quantity by Application (2018-2023) & (Kg)
Table 97. South America Capecitabine Sales Quantity by Application (2024-2029) & (Kg)
Table 98. South America Capecitabine Sales Quantity by Country (2018-2023) & (Kg)
Table 99. South America Capecitabine Sales Quantity by Country (2024-2029) & (Kg)
Table 100. South America Capecitabine Consumption Value by Country (2018-2023) & (USD Million)
Table 101. South America Capecitabine Consumption Value by Country (2024-2029) & (USD Million)
Table 102. Middle East & Africa Capecitabine Sales Quantity by Type (2018-2023) & (Kg)
Table 103. Middle East & Africa Capecitabine Sales Quantity by Type (2024-2029) & (Kg)
Table 104. Middle East & Africa Capecitabine Sales Quantity by Application (2018-2023) & (Kg)
Table 105. Middle East & Africa Capecitabine Sales Quantity by Application (2024-2029) & (Kg)
Table 106. Middle East & Africa Capecitabine Sales Quantity by Region (2018-2023) & (Kg)
Table 107. Middle East & Africa Capecitabine Sales Quantity by Region (2024-2029) & (Kg)
Table 108. Middle East & Africa Capecitabine Consumption Value by Region (2018-2023) & (USD Million)
Table 109. Middle East & Africa Capecitabine Consumption Value by Region (2024-2029) & (USD Million)
Table 110. Capecitabine Raw Material
Table 111. Key Manufacturers of Capecitabine Raw Materials
Table 112. Capecitabine Typical Distributors
Table 113. Capecitabine Typical Customers
List of Figures
Figure 1. Capecitabine Picture
Figure 2. Global Capecitabine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Capecitabine Consumption Value Market Share by Type in 2022
Figure 4. 500 mg Examples
Figure 5. 150 mg Examples
Figure 6. Global Capecitabine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Capecitabine Consumption Value Market Share by Application in 2022
Figure 8. Breast Cancer Examples
Figure 9. Colorectal Cancer Examples
Figure 10. Stomach Cancer Examples
Figure 11. Global Capecitabine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Capecitabine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Capecitabine Sales Quantity (2018-2029) & (Kg)
Figure 14. Global Capecitabine Average Price (2018-2029) & (USD/g)
Figure 15. Global Capecitabine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Capecitabine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Capecitabine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Capecitabine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Capecitabine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Capecitabine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Capecitabine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Capecitabine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Capecitabine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Capecitabine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Capecitabine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Capecitabine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Capecitabine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Capecitabine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Capecitabine Average Price by Type (2018-2029) & (USD/g)
Figure 30. Global Capecitabine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Capecitabine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Capecitabine Average Price by Application (2018-2029) & (USD/g)
Figure 33. North America Capecitabine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Capecitabine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Capecitabine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Capecitabine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Capecitabine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Capecitabine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Capecitabine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Capecitabine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Capecitabine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Capecitabine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Capecitabine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Capecitabine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Capecitabine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Capecitabine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Capecitabine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Capecitabine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Capecitabine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Capecitabine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Capecitabine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Capecitabine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Capecitabine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Capecitabine Market Drivers
Figure 74. Capecitabine Market Restraints
Figure 75. Capecitabine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Capecitabine in 2022
Figure 78. Manufacturing Process Analysis of Capecitabine
Figure 79. Capecitabine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs